Xenofocus Signs Supply Contract Worth 10.8823 Billion KRW
[Asia Economy Reporter Oh Ju-yeon] Genofocus announced on the 14th that it has signed a supply agreement on Lactazyme-B enzyme worth 10,882,230,000 KRW in the United Kingdom. This amount corresponds to 72.83% of recent sales. The contracting party withheld disclosure at the request of trade secret protection.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- Court Partially Grants Samsung Electronics' Injunction to Prohibit Industrial Action... 100 Million Won Penalty Per Day for Violations
- President Lee Attends Gwangju May 18 Ceremony... Declares 'A Nation Where the People Are the True Owners' at Democratic Cemetery
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
